Ocular side effects in chronic myeloid leukemia patients treated with imatinib

Leukemia Research

Volumn 32, Issue 7, 2008, Pages 1022-1025

  Breccia, Massimo ^a   Gentilini, Fabiana ^a   Cannella, Laura ^a   Latagliata, Roberto ^a   Carmosino, Ida ^a   Frustaci, Annamaria ^a   Alimena, Giuliana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic myeloid leukaemia; Imatinib; Ocular side events

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; DIURETIC AGENT; HYDROXYUREA; IMATINIB; INTERFERON; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME INHIBITION; EYE TOXICITY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; MYOPIA; OPTIC NEURITIS; PERIORBITAL EDEMA; PRIORITY JOURNAL; RETINA HEMORRHAGE; SIDE EFFECT; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; EDEMA; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; ORBITAL DISEASES; PIPERAZINES; PYRIMIDINES;

EID: 41949112519     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.10.016     Document Type: Article

References (8)

1. Druker B.J., Guilhot F., O'Brien S.G., et al. Five years follow-up of patients receiving imatinib for chronic myeloid leukaemia. New Engl J Med 355 (2006) 2408-2417
2. Esmaeli B., Prieto V.G., Butler C.E., et al. Severe periorbital edema secondary to STI571. Cancer 95 (2002) 881-887
3. Esmaeli B., Diba R., Ahmadi M.A., et al. Periorbital edema and epiphora as ocular side effects of imatinib mesylate. Eye 18 (2004) 760-762
4. Ramar K., Potti A., and Mehdi S.A. Periorbital edema and imatinib mesylate therapy for chronic myeloid leukaemia. J Clin Oncol 21 (2003) 172-173
5. Maalouf T., Angioi K., Champigneulle J., Guerci A., and George J.L. Oedeme palpebral secondairie au traitement par inhibiteur de la tyrosine kinase: Glivec. J Fr Ophtalmol 27 (2004) 107-109
6. Fraunfelder F.W., Solomon J., Druker B.J., Esmaeli B., and Kuyl J. Ocular side-effects associated with imatinib mesylate. J Ocul Pharmacol Ther 19 (2003) 371-375
7. Stahl J.L., Cook E.B., Graziano F.M., and Barney M.P. Human conjunctival mast cells: expression of Fc epsilonRI, c-kit, ICAM-1, and IgE. Arch Ophthalmol 117 (1999) 493-497
8. Govind Babu K., Satya Suresh Attili V., Bapsy P.P., and Anupama G. Imatinib induced optic neuritis in a patient of CML. Int Ophtalmol 27 (2007) 43-44